| Literature DB >> 35947272 |
Miharu Tamaoki1, Ikumi Honda2, Keisuke Nakanishi1, Sophathya Cheam3, Manabu Okawada3, Hisataka Sakakibara4.
Abstract
BACKGROUND: The incidence of noncommunicable diseases, such as cardiovascular diseases and diabetes mellitus, is increasing in Cambodia. Urbanization and lifestyle changes due to rapid economic development have affected the components of metabolic syndrome (MetS). This study aimed to determine the prevalence of MetS, MetS components, and health status among Cambodians living in urban areas.Entities:
Keywords: Cambodia; Metabolic syndrome; Noncommunicable diseases; Urbanization
Mesh:
Year: 2022 PMID: 35947272 PMCID: PMC9470791 DOI: 10.1007/s44197-022-00053-5
Source DB: PubMed Journal: J Epidemiol Glob Health ISSN: 2210-6006
Characteristics of participants
| Men | Women | |
|---|---|---|
| Age (years) | 46.9 ± 14.5 | 49.3 ± 15.7 |
| BMI | 25.4 ± 3.6 | 23.9 ± 3.9 |
| Waist circumference (cm) | 88.5 ± 10.1 | 80.3 ± 10.7 |
| Triglycerides (mg/dL) | 149 (103–223) | 110 (75–167) |
| HDL cholesterol (mg/dL) | 41.9 ± 10.6 | 49.3 ± 12.9 |
| LDL cholesterol (mg/dL) | 128.5 ± 35.1 | 125.4 ± 35.7 |
| Systolic blood pressure (mmHg) | 128.6 ± 16.3 | 122.2 ± 19.2 |
| Diastolic blood pressure (mmHg) | 84.5 ± 11.1 | 77.8 ± 11.3 |
| Fasting blood glucose (mg/dL) | 110.1 ± 33.4 | 103.8 ± 27.6 |
| HbA1c (%) | 5.8 ± 0.98 | 5.8 ± 0.96 |
Data are presented as means ± standard deviations or medians (interquartile ranges)
BMI body mass index, HDL-cholesterol high-density lipoprotein cholesterol, LDL-cholesterol low-density lipoprotein cholesterol
Prevalence of MetS and MetS components
| Men ( | Women ( | ||
|---|---|---|---|
| % (95% CI) | % (95% CI) | ||
| Metabolic syndrome | 60.1 (58.4–61.8) | 52.4 (50.6–54.2) | < 0.001 |
| Abdominal obesity | 44.8 (43.1–46.6) | 53.9 (52.1–55.7) | < 0.001 |
| Hypertriglyceridemia | 52.3 (50.6–54.1) | 33.5 (31.8–35.2) | < 0.001 |
| Low HDL cholesterol | 48.6 (46.8–50.3) | 56.4 (54.6–58.2) | < 0.001 |
| Elevated blood pressure | 73.2 (71.6–74.7) | 65.3 (63.5–67.0) | < 0.001 |
| Elevated fasting blood glucose | 66.1 (64.5–67.8) | 53.3 (51.4–55.0) | < 0.001 |
*Age-adjusted p value
Fig. 1Prevalence of metabolic syndrome (MetS) by age (%)
Fig. 2Number of metabolic syndrome components and percentage prevalence by age
Fig. 3Prevalence of metabolic components by age
Prevalence of hypertension, diabetes, and dyslipidemia in the MetS or non-MetS groups
| Men ( | Women ( | |||||
|---|---|---|---|---|---|---|
| MetS ( | Non-MetS ( | MetS ( | Non-MetS (1388) | |||
| Hypertensiona | 891 (77.7) | 255 (22.3) | < 0.001 | 536 (78.9) | 255 (22.3) | < 0.001 |
| Diabetesb | 415 (87.9) | 57 (12.1) | < 0.001 | 338 (93.1) | 25 (6.9) | < 0.001 |
| Dyslipidemiac | 1633 (80.2) | 403 (19.8) | < 0.001 | 979 (84.3) | 182 (15.7) | < 0.001 |
*Age-adjusted p value
aHypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg
bDiabetes: HbA1c ≥ 6.5% or fasting blood glucose ≥ 126 mg/dL
cDyslipidemia: total glyceride ≥ 150 mg/dL or HDL cholesterol < 40 mg/dL
Prevalence of hypertension, diabetes, and dyslipidemia and the rate of untreated participants
| Men ( | Women ( | |||
|---|---|---|---|---|
| Hypertensiona | 1146 | (36.1) | 679 | (23.3) |
| Diabetesb | 472 | (15.3) | 363 | (12.8) |
| Dyslipidemiac | 2036 | (64.1) | 1161 | (39.8) |
| Untreated participantsd | ||||
| Hypertensiona | 528 | (46.1) | 271 | (39.9) |
| Diabetesb | 209 | (44.3) | 135 | (37.2) |
| Dyslipidemiac | 1917 | (94.2) | 1085 | (93.5) |
aHypertension: systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg
bDiabetes: HbA1c ≥ 6.5% or fasting blood glucose ≥ 126 mg/dL
cDyslipidemia: total glyceride ≥ 150 mg/dL or HDL cholesterol < 40 mg/dL
dThe denominator is the number of people included in prevalence